Efficacy and Safety Active Not Recruiting Phase 2 Trials for Pemetrexed (DB00642)

IndicationStatusPhase
DBCOND0085675 (Efficacy and Safety)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03623776Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.Treatment